A robust CD8+ T cell-related classifier for predicting the prognosis and efficacy of immunotherapy in stage III lung adenocarcinoma.

Patients with stage III lung adenocarcinoma (LUAD) have significant survival heterogeneity, meanwhile, CD8+ T cell has a remarkable function in immunotherapy. Therefore, developing novel biomarkers based on CD8+ T cell can help evaluate the prognosis and guide the strategy of immunotherapy for patients with stage III LUAD. Thus, we abstracted twelve datasets from multiple online databases and grouped the stage III LUAD patients into training and validation sets. We then used WGCNA and CIBERSORT, while univariate Cox analysis, LASSO analysis, and multivariate Cox analysis were performed. Subsequently, a novel CD8+ T cell-related classifier including HDFRP3, ARIH1, SMAD2, and UPB1 was developed, which could divide stage III LUAD patients into high- and low-risk groups with distinct survival probability in multiple cohorts (all P < 0.05). Moreover, a robust nomogram including the traditional clinical parameters and risk signature was constructed, and t-ROC, C-index, and calibration curves confirmed its powerful predictive capacity. Besides, we detected the difference in immune cell subpopulations and evaluated the potential benefits of immunotherapy between the two risk subsets. Finally, we verified the correlation between the gene expression and CD8+ T cells included in the model by immunohistochemistry and validated the validity of the model in a real-world cohort. Overall, we constructed a robust CD8+ T cell-related risk model originally which could predict the survival rates in stage III LUAD. What's more, this model suggested that patients in the high-risk group could benefit from immunotherapy, which has significant implications for accurately predicting the effect of immunotherapy and evaluating the prognosis for patients with stage III LUAD.

A terrifying sound stress inhibits hippocampal neurogenesis in the adult male mice.

Stress impairs hippocampal neurogenesis. The traditional animal model of stress contains a mixture of physical and psychological stress factors. This leads to difficulty in the evaluation of the effect of pure psychological stress on neurogenesis. In this study, we investigated the effect of pure psychological stress on hippocampal neurogenesis. The pure psychological stress model and the mixed stress model were carried out by terrifying sound and restraint, respectively. The open field test showed that restraint treatment improved the general locomotor activity levels, while terrifying sound treatment had opposite effects. Compared with a normal condition, both terrifying sound stimulation and restraint treatment significantly decreased the number of BrdU and Ki-67 and reduced the positive rate of SOX2/GFAP in the hippocampus. These phenomena indicated that pure psychological stress could decrease the number of neural stem cells and inhibit cell proliferation in the hippocampus of a mouse. Furthermore, compared with the restraint treatment, the neurotransmitters including norepinephrine (NE), 5-hydroxytryptamine (5-HT), and gamma-aminobutyric acid (GABA) had not been affected drastically by terrifying sound stimulation. Our results suggest that the terrifying sound stimulation can be considered as a novel and effective pure psychological stress animal model for the further research on the hippocampus.

The Influence of Blood Collection Tubes in Biomarkers' Screening by Mass Spectrometry.

PURPOSE: Mass spectrometry is one of the rapidly developing bio-analytical techniques in recent years, and it shows that the results of biomarkers' screening can be influenced by pre-analytical process. The selection of the blood collection tubes is one of the most significant steps of pre-analytical process which is often neglected by researchers. So, it is urgent to define the influence of blood collection tubes clearly in biomarkers' screening. EXPERIMENTAL DESIGN: Two types of blood collection tubes, non-additive tubes and coagulant activator tubes, are used to collect serum samples from patients and healthy controls. All samples are analyzed using matrix-assisted laser desorption ionization-time of flight mass spectrum in this study. RESULTS: The serum protein profile changes while using coagulant tubes whether for patients or healthy controls. It is found that the effect of coagulant on serum protein of patients is smaller than that of control group. There are 27 significantly different peaks between the control group and the control coagulant group. However, between patient group and patient coagulant group, only one differential peak is obtained. Coagulant changes the expression differences between patients and healthy controls, making the differences expand, shrink or reverse, and most of the polypeptides are small molecule, which will change the results of biomarker's screening. CONCLUSIONS AND CLINICAL RELEVANCE: This research suggested that different types of blood collection tubes would influence the final laboratory results. So it's important for clinicians to choose the proper tubes to detect biomarkers and make correct diagnoses.